Formulating Poorly Water Soluble Drugs

Formulating Poorly Water Soluble Drugs

Robert O. Williams III, Daniel A. Davis Jr., Dave A. Miller
이 책이 얼마나 마음에 드셨습니까?
파일의 품질이 어떻습니까?
책의 품질을 평가하시려면 책을 다운로드하시기 바랍니다
다운로드된 파일들의 품질이 어떻습니까?
The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist’s approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound’s physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.
년:
2021
판:
3
출판사:
Springer
언어:
english
페이지:
855
ISBN 10:
1461411432
ISBN 13:
9781461411437
시리즈:
978-3030887186
파일:
EPUB, 79.42 MB
IPFS:
CID , CID Blake2b
english, 2021
로의 변환이 실행 중입니다
로의 변환이 실패되었습니다

주로 사용되는 용어